Clinical Trial: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Feasibility of Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Brief Summary: The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of the 10 patients (50%) will achieve an absolute increase of lymphocyte counts of 300 cells/mm^3 four weeks after stem cell reinfusion in high grade glioma patients.